• Phytotherapy of menopausal disorders
en To content

Phytotherapy of menopausal disorders

HEALTH OF WOMAN. 2019.9(145): 58–63; doi 10.15574/HW.2019.145.58
A.O. Islamova
SI «Institute of pediatrics, obstetrics and ginecology named academic Elena. M. Lukyanova NAMS of Ukraine»

A study to examine the efficacy and safety of drug Menomedin in patients with climacteric disorders of mild to moderate severity in late reproductive period was performed.

The average menopausal index, according to a Menopause Rating Scale (MRS), was significantly lower after treatment (8.6±0.1) than before treatment (23.2±0.5). In all examined women hormone levels corresponded to perimenopausal values. Side effects and individual intolerance reactions were not observed. Antiatherosclerotic effect was detected during treatment Menomedin.

Author of the study conclude that a good level of efficacy and safety Menomedin allows to use it at the earliest manifestations of menopausal disorders in women in the late reproductive period (perimenopause).

Key words: climacteric syndrome, perimenopause, Menomedin.


1. Pyrohova VI, Veresniuk NS, Malachynska MI. 2015. Efektyvna fitoterapiia klimakterychnyh porushen. Obstetrics.Gynecology.Genetics. 1: 69–72.

2. Tatarchuk TF, Islamova AO. 2012. Problemyi menopauzyi – realiii perspektivy. Reproduktivnaya endokrinologiya 6:59–62.

3. Tatarchuk TF, Efimenko OA, Islamova AO. 2013. Menopauza: novyiy vzglyad na staruyu problemu. Reproduktivnaya endokrinologiya 1: 7–13.

4. Kosilova SE. 2015. Nehormonalna korektsiia klimakterychnykh rozladiv u zhinok u postmenopauzi. Bukovynskyi medychnyi visnyk 19;2 (74): 113–115.

5. Menopause State of the art. Ed. by Iole Di Francesco: 540. 2011.

6. Meditsina klimakteriya. Pod red. Smetnik VP. M: 848. 2006.

7. Tatarchuk TF, Yefymenko OO. 2009. Pryntsypy diahnostyky, profilaktyky ta likuvannia klimakterychnykh rozladiv. Zhurnal ukrainskoi likarskoi elity 4 (10): 24–29.

8. Cleve A, Fritzemeier KH, Haendler B et al. 2012. Pharmacology and clinical use of sex steroid hormone receptor modulators. Handb Exp Pharmacol. 214: 543–587. https://doi.org/10.1007/978-3-642-30726-3_24; PMid:23027466

9. Reznichenko HI, Reznichenko NIu, Potebnia VIu, Kovalenko KI, Onishchenko RA. 2016. Mozhlyvosti korektsii klimakterychnykh rozladiv u zhinok iz zastosuvanniam preparatu Menopeis. Zdorove zhenshchyny 5: 95–100.

10. Karnauh EV. 2014. Fitoestrogennyie preparatyi tsimitsifugi pri klimaktericheskom sindrome. Teoretichna I eksperimentalna meditsina 4 (65): 33–38.

11. Ying C et al. 2001. Growth inhibition of human endothelial cells by the phyto-oestrogen biochanin A, a metabolite of genistein. Br J Nutr. 85(5): 615–620. https://doi.org/10.1079/BJN2000290; PMid:11348577

12. Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A. 2003. Comparison of hormonal activity (estrogen, androgen, and progestin) of standardized plant extract for large scale use in hormone replacement therapy. J of Steroid Biochem & Molecular Biology 1831: 1–10.

13. Hechtman Leah. 2012. Clinical naturopatic medicine. Elsevier Health Sciences APAC, Chatswood: 1610,  ISBN 978-0729541510, p.128-131.

14. Moran Amy E, Carothers Adelaide M, Weyant Michael J et al. 2005. Carnosol Inhibits b-Catenin Tyrosine Phosphorylation and Prevents Adenoma Formation in the C57BL/6J/Min/+ (Min/+) Mouse. Cancer Res 65:1097-1104. Published online 2005, February 10.

15. Kianbakht S, Dabaghian FH. 2013. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial. Complement Ther Med. 21;5: 441–446. https://doi.org/10.1016/j.ctim.2013.07.004; PMid:24050577

16. Kianbakht S, Abasi B, Perham M, Dabaghian HF. 2011. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial. Phytother Res. 25;12: 1849–1853. https://doi.org/10.1002/ptr.3506; PMid:21506190

17. Rahte S, Evans R, Eugster PJ et al. 2013. Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles. Planta Med.79; 9: 753–760. https://doi.org/10.1055/s-0032-1328552; PMid:23670626

18. Assessment report on Salvia officinalis L, folium and Salvia officinalis L. aetheroleum. European Medicines Agency. London. 2009, November 12.

19. Farmatsevtychna entsyklopediia. Holova red. rady ta avtor peredmovy Chernykh VP. 2-e vyd, pererobl. i dopovn. K, «Morion», 2010:1632, il: 16. ISBN 978-966-2066-34-0.

20. Assessment report on Angelica sinensis. European Medicines Agency. London. 2013, July 9.

21. Borrelli F, Ernst E. 2008. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res, 58:8–14. https://doi.org/10.1016/j.phrs.2008.05.008; PMid:18585461

22. Assessment report on Cimicifuga racemosa. European Medicines Agency. London. 2010, November 25.

23. Tatarchuk TF, Efimenko OA. 2012. Sovremennyiy vzglyad na gormonalnuyu terapiyu. Reproduktivnaya endokrinologiya 2 (4): 34–39.